[1]
2016. Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP). ADMET and DMPK. 4, 4 (Dec. 2016), 302–313. DOI:https://doi.org/10.5599/admet.4.4.322.